Aralez Pharmaceuticals Stock Market Capitalization
Aralez Pharmaceuticals fundamentals help investors to digest information that contributes to Aralez Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Aralez Stock. The fundamental analysis module provides a way to measure Aralez Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aralez Pharmaceuticals stock.
Aralez |
Aralez Pharmaceuticals Company Market Capitalization Analysis
Aralez Pharmaceuticals' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Aralez Pharmaceuticals Market Capitalization | 17.93 M |
Most of Aralez Pharmaceuticals' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aralez Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
CompetitionBased on the recorded statements, the market capitalization of Aralez Pharmaceuticals is about 17.93 M. This is 99.86% lower than that of the sector and 99.64% lower than that of the Market Capitalization industry. The market capitalization for all United States stocks is 99.91% higher than that of the company.
Aralez Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aralez Pharmaceuticals' direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aralez Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Aralez Pharmaceuticals by comparing valuation metrics of similar companies.Aralez Pharmaceuticals is currently under evaluation in market capitalization category among related companies.
Aralez Fundamentals
| Return On Equity | -262.08 | |||
| Return On Asset | -6.75 | |||
| Profit Margin | (99.50) % | |||
| Operating Margin | (45.33) % | |||
| Current Valuation | 233.57 M | |||
| Shares Outstanding | 67.19 M | |||
| Shares Owned By Insiders | 9.58 % | |||
| Shares Owned By Institutions | 8.27 % | |||
| Number Of Shares Shorted | 2.97 M | |||
| Price To Earning | (0.85) X | |||
| Price To Book | 2.21 X | |||
| Price To Sales | 0.15 X | |||
| Revenue | 118.06 M | |||
| Gross Profit | 92.44 M | |||
| EBITDA | (17.23 M) | |||
| Net Income | (117.47 M) | |||
| Cash And Equivalents | 43.89 M | |||
| Cash Per Share | 0.65 X | |||
| Total Debt | 274.57 M | |||
| Current Ratio | 0.80 X | |||
| Book Value Per Share | (0.10) X | |||
| Cash Flow From Operations | (20.7 M) | |||
| Short Ratio | 2.14 X | |||
| Earnings Per Share | (1.76) X | |||
| Number Of Employees | 164 | |||
| Beta | 0.88 | |||
| Market Capitalization | 17.93 M | |||
| Total Asset | 32.26 M | |||
| Retained Earnings | (134.69 M) | |||
| Working Capital | 15.52 M | |||
| Current Asset | 32.01 M | |||
| Current Liabilities | 16.49 M | |||
| Z Score | -2.6 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| C | Citigroup | |
| CRM | Salesforce | |
| MSFT | Microsoft |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Aralez Stock
If you are still planning to invest in Aralez Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aralez Pharmaceuticals' history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |